In recent years, weight management medications have revolutionized the weight loss world
Introducing retatrutide Retatrutide is a new medication that targets the glucose-dependent insulinotropic polypeptide (GIP receptor), glucagon-like peptide-1 (GLP-1), and glucagon receptors (GCG receptors)
signs like rash, itching, or swelling would necessitate immediate medical attention
Existing observational studies comparing weight reduction with these two treatments were conducted in patients with and without type 2 diabetes before FDA approval of tirzepatide for obesity management [8,9,10,11,12,13,14,15]
Weight loss varies but can be substantial
What bloodwork does Marek Health require